ARDS secondary to descending necrotizing mediastinitis treated by long-term extracorporeal respiratory support by Franchi, Federico et al.
ARDS Secondary to Descending Necrotizing Mediastinitis
Treated By Long-Term Extracorporeal Respiratory Support
Federico Franchi MD, Riccardo Silvestri MD, Lucia Cubattoli MD, Luca Voltolini MD,
Maria Antonietta Mazzei MD, and Pierpaolo Giomarelli MD
Introduction
Acute respiratory distress syndrome (ARDS) may be a
severe complication of descending necrotizing mediastini-
tis (DNM) that dramatically increases mortality in conven-
tionally treated patients.1 Extracorporeal respiratory sup-
port in case of ARDS secondary to DNM represents a hard
challenge, as a very severe clinical condition is treated
with a complex technique. Here we describe a case of
ARDS secondary to a DNM managed with veno-venous
extracorporeal membrane oxygenation (ECMO).
Case Summary
A 28-year-old previously healthy man (weight 90 kg,
height 180 cm) was referred to our hospital for a septic
condition associated with an odontogenic abscess. Despite
abscess drainage and empiric broad-spectrum antibiotics,
the patient developed a severe respiratory failure second-
ary to descending mediastinitis. A chest computed tomog-
raphy (CT) scan showed that the infection was extending
to the lower anterior and posterior mediastinum (type IIB
DNM, according to Endo et al’s classification)2 (Fig. 1).
The patient underwent surgical treatment, which con-
sisted of debridement of necrotic tissue and drainage of
infected fluid collections through a neck collar incision
and right thoracotomy. Then he was transferred to the
postoperative ICU. Subsequently, the patient developed a
progressive impairment of gas exchange and ARDS (PaO2/
FIO2 170 mm Hg, pH 7.31, PaCO2 74 mm Hg). Volume
controlled ventilation with lung-protective strategy (pla-
teau pressure  30 cm H2O) was adopted: tidal volume
(VT)  6 mL/kg, respiratory rate 20–22 breaths/min, and
PEEP 10 cm H2O. Nevertheless, respiratory acidosis wors-
ened until pH dipped to 7.23, with PaCO2 90 mm Hg.
Therefore, an extracorporeal veno-venous respiratory sup-
port with CO2 removal (DECAP CO2 Remover, Estor,
Pero, Milano, Italy) was started. Six days later, since clin-
ical conditions and gas exchange were not improved (PaO2/
FIO2 150 mm Hg, pH 7.31, PaCO2 72 mm Hg, compliance
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Fig. 1. Multiplanar reconstruction reformatted on oblique sagittal
plane, demonstrating the abscess progression through the cervi-
cal spaces, down into the mediastinum and the retrosternal space
(arrowhead) and posterior mediastinum (asterisks).
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25 mL/cm H2O), the patient was transferred to our ICU for
ECMO treatment.
Clinical data at admission were: body temperature
35.5°C, arterial pressure 140/75 mm Hg, heart rate
112 beats/min. Laboratory tests showed leukocytosis
(14,000 cells/mL) and increase of both C-reactive protein
(18 mg/mL) and procalcitonin (4 ng/mL). CT scan re-
vealed a massive bilateral consolidation of the lungs, un-
responsive to recruitment maneuvers. The maneuvers were
performed by changing the ventilator mode to continuous
positive airway pressure and rapidly increasing the PEEP
level up to 40 cm H2O for 40 seconds. During the recruit-
ment maneuver, the maximum peak airway pressure tol-
erated was 40 cm H2O. The procedure was stopped in case
of hypotension (systolic arterial pressure  90 mm Hg) or
severe hypoxemia (SpO2  80%) (see Fig. 2). The arterial
blood gas analysis during CO2 removal showed hypox-
emia (PaO2/FIO2 140 mm Hg) and respiratory acidosis(pH 7.30, PaCO2 70 mm Hg). In spite of severe signs of
infection, no microorganisms were isolated in any sites or
in surgical drainage fluid, and the patient was empirically
treated with teicoplanin and amikacin.
For one day CO2 removal, protective ventilation, and
recruitment maneuvers were continued, but despite pro-
tective ventilatory settings (volume controlled ventilation
with VT 6 mL/kg, respiratory rate 24 breaths/min,
PEEP 14 cm H2O) we didn’t obtain a reduction of plateau
pressure, which started to overcome 30 cm H2O (32–
35 cm H2O) as the static pulmonary compliance was de-
creased to 10 mL/cm H2O. Gas exchange and respiratory
acidosis worsened until PaO2/FIO2 of 90 mm Hg, PaCO2 of
85 mm Hg, and pH of 7.28. Therefore, we decided to
switch the extracorporeal respiratory support into a veno-
venous ECMO through a veno-venous percutaneous
femoro-femoral bypass. After systemic heparinization, two
21 French cannulas were inserted: one from the right fem-
oral vein, with the tip in right atrium, the other from the
left femoral vein with the tip in the inferior vena cava. The
venous blood, driven by a centrifugal pump (Jostra Rota-
flow, Maquet Cardiopulmonary, Hechingen, Germany),
was drained from the inferior vena cava, pumped through
an artificial lung (Jostra Quadrox PLS, Maquet Cardiopul-
monary, Hechingen, German), and then re-infused into the
right atrium. Extracorporeal blood flow was set to 3.5 L/
min and artificial lung gas flow to 7 L/min. A pulse con-
tour system (MostCare, Vytech/Vygon Italia, Padova, It-
aly)3 provided hemodynamic monitoring. Anticoagulation
was achieved with unfractionated heparin infusion titrated
to obtain an activated partial thromboplastin time of 65–
80 seconds. During the first days the respiratory dead space
was 90%; thus, with ECMO support, we could set a vol-
ume controlled ventilation with a VT  4 mL/kg, PEEP of
20 cm H2O (maintaining plateau pressure  30 cm H2O),
respiratory rate of 8 breaths/min, and FIO2 of 1.0, achieving
a gradual correction of respiratory acidosis (PaCO2
45 mm Hg, pH 7.46) and a moderate improvement of
oxygenation (PaO2/FIO2 150 mm Hg).
On the 4th day, bronchoalveolar lavage and blood cul-
ture were positive for a multiple-drug-resistant Pseudomo-
nas aeruginosa. Treatment with teicoplanin was stopped,
and a combined therapy with intravenous meropenem and
intravenous plus endobronchial amikacin was started.
On the 14th day, despite heparin and antithrombin III
continuous infusion to guarantee a stable antithrombin III
activity 80%, a drop of blood flow occurred. No clots in
the external circuit were detected, and a CT scan showed
the presence of a blood clot in the in-flow cannula (see
Fig. 3). Therefore, we replaced both the cannulas with 2 of
Fig. 2. Thin section chest computed tomogram performed with
different PEEP values, demonstrating poor recruitment of lung pa-
renchyma in ARDS condition.
Fig. 3. Multiplanar reconstruction reformatted on coronal planes
shows venous thromboses associated with catheter at first extra-
corporeal membrane oxygenation catheter placement.
ARDS SECONDARY TO DESCENDING NECROTIZING MEDIASTINITIS
RESPIRATORY CARE • NOVEMBER 2012 VOL 57 NO 11 1971
a larger caliber (23 French). Eight days later the cannulas
were replaced again because of new clot formation (Fig. 4).
On this occasion a systemic coagulation screening dem-
onstrated heparin-reactive antibodies, with a weak activity
not inducing platelet aggregation. After this episode no
other problems with the cannulas occurred. On the 20th
day a bronchoalveolar lavage positive for a carbapenems-
resistant Pseudomonas aeruginosa required a modification
of therapy to ciprofloxacin and aerosolized colistin. The
stay of the patient was complicated by acute cholecystitis,
empirically treated with intravenous tigecycline and after-
wards, on the 21st day of ECMO, with a cholecystotomy.
Subsequently, ventilatory parameters gradually improved
along with clinical conditions: on the 23rd day PaO2/FIO2
170 mm Hg, pH 7.45, PaCO2 43 mm Hg, compliance 28 mL/
cm H2O.
A new CT scan performed on the 25th day showed a
substantial improvement of mediastinal and pulmonary
framework (Fig. 5). The patient was weaned from ECMO
after 34 days, and from mechanical ventilation 23 days
later. Antibiotic therapy was discontinued on the 50th day
of stay. He was transferred from the ICU to the Department
of Respiratory Physiopathology for rehabilitation, 65 days
after admission. He was discharged from hospital 14 days
later, with a vital capacity of 50% of predicted.
Discussion
DNM resulting from necrotizing fasciitis of the neck is
a rare and serious disease, which has a dramatic prognosis
and a mortality that varies in the literature from 14% to
50%.1 One of the most common complications is lung
involvement, directly, through the extension of the inflam-
matory process, and/or indirectly, through the establish-
ment of a septic state.4 Even with early diagnosis and the
institution of an appropriate medical and surgical therapy,
mortality remains high. A meta-analysis showed that for a
second type IIB mediastinitis, surgical treatment with cer-
vicotomy was burdened with a mortality of 47%, com-
pared with 19% among the patients treated with cervi-
cotomy and thoracotomy.5 In this scenario, the target of
early diagnosis and effective treatment is to minimize as
much as possible the mortality.6
Together with surgery, an aggressive medical therapy,
aimed at the treatment of primary infection and manage-
ment of the complications associated with the disease, is
mandatory. In our patient the conventional treatment of
ARDS was not sufficient to ensure adequate control of
either acidosis or pulmonary pressures. Respiratory sup-
port with CO2 removal was therefore considered because
it is relatively simple to establish7 and to manage. It con-
sists of a veno-venous shunt system, with a circuit similar
to that of continuous renal replacement therapy. However,
the technique, given the low blood flows (approximately
400 mL/min), provides a limited removal of CO2 and can-
not enhance blood oxygenation. Furthermore, a daily re-
placement of the circuit is needed.
In our patient this approach became insufficient when
the clinical conditions worsened. Veno-venous ECMO, by
supporting greater blood flows (0.5–7 L/min), allows
greater CO2 removal and can provide blood oxygenation.
Fig. 4. Extracorporeal membrane oxygenation catheter thrombo-
sis after second placement.
Fig. 5. Thin section chest computed tomogram performed before
discharge, demonstrating partial resolution of ARDS condition with
fibrosis evolution.
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Initially, given the size of the cannulas (21 French), the
contribution to oxygenation was low (PaO2 65 mm Hg). In
fact, we obtained blood flows of about 3–3.5 L/min, which
accounted for half of the cardiac output of our septic pa-
tient. However, the blood flow was still sufficient to en-
sure adequate CO2 removal and, consequently, an over-
protective controlled ventilation (VT  4 mL/kg), which
was our primary intention. During the first period, an FIO2
of 1.0 and daily recruitment maneuvers were indispensable
to maintain an acceptable oxygenation (pronation of the
patient was avoided, given the presence of the chest drain-
ages).8
Pulmonary artery catheter is necessary for monitoring
hemodynamics as well as the proportion of shunt, the mixed
venous saturation, and the ratio of cardiac output to blood
flow during an ECMO treatment. However, the site of the
infection and the surgery wounds made us desist from
inserting a pulmonary artery catheter. Thus, hemodynamic
parameters were obtained by transthoracic echocardiogra-
phy and by the pulse contour system,3 which allowed us
continuous cardiac output monitoring. Therefore, we could
set blood flow in relation to cardiac output changes, mon-
itoring “online” the cardiac output/blood flow ratio.
After 7 days of ECMO support, PaCO2 was 58 mm Hg
and pH was 7.42. On the 14th day the 21 French cannulas
were replaced with larger cannulas (23 French) because of
the presence of blood clots. This allowed us to increase the
extracorporeal blood flow up to 4.5 L/min, with a conse-
quent improvement of blood oxygenation. The cannulas
were replaced another time for the same reason, in spite of
a constant control and optimization of coagulation assess-
ment (heparin and ATIII infusion, blood products transfu-
sions). The blood tests showed the absence of functional
heparin reactive antibodies, so this condition was probably
secondary to the sepsis-related impairment of coagulation.9
Teaching Points
• Our experience confirms that ECMO treatment is sub-
ject to several potential complications and requires a
skilled staff. Considering the high mortality rate reported
among patients with respiratory failure related to DNM
and sepsis, this treatment should be considered in the
early stage of the disease.
• CO2 removal does not allow oxygenation and, given the
low blood flows, is unable to remove a large amount of
CO2. However, in selected patients it may be a valuable
aid if applied very early.
• Extracorporeal assistance may enhance the coagulation
impairment due to sepsis.
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